Interesting to read the thoughts of a fellow investor from 3 years ago .. the thesis still remains the same even after 3 years. Although, I have hopes from the new management but have a starter position so not worried about large losses yet. I have added my notes in case anyone is still tracking this compnay.

I've folowed OSL for a few years now and recently bought back in at ~14c. Following CE mark approval and providing the data from ongoing trials continues to be positive I wouldn't be surprised to see a take-over on the horizon. Still a significant amount of work to do but I now see some short term catalysts which should help drive share price momentum. Remains a high risk high reward play.